Valuing Pharmaceutical Companies: A Guide to the Assessment and Evaluation of Assets, Performance and Prospects
Author:   Karen Beynon ,  Andrew Porter
Publisher:   Elsevier Science & Technology
ISBN:  

9781855734586


Pages:   192
Publication Date:   19 June 2000
Format:   Hardback
Availability:   Out of stock   Availability explained


Our Price $673.20 Quantity:  
Add to Cart

Share |

Valuing Pharmaceutical Companies: A Guide to the Assessment and Evaluation of Assets, Performance and Prospects


Add your own review!

Overview

Full Product Details

Author:   Karen Beynon ,  Andrew Porter
Publisher:   Elsevier Science & Technology
Imprint:   Woodhead Publishing Ltd
Dimensions:   Width: 15.60cm , Height: 1.70cm , Length: 23.40cm
Weight:   0.500kg
ISBN:  

9781855734586


ISBN 10:   1855734583
Pages:   192
Publication Date:   19 June 2000
Audience:   General/trade ,  General
Format:   Hardback
Publisher's Status:   Unknown
Availability:   Out of stock   Availability explained

Table of Contents

Part 1 The global pharmaceutical industry: Pharmaceuticals and the treatment of disease; Structure and internationalisation of the industry; Regional and national developments; Major changes in the pharmaceutical industry. Part 2 Analysis and evaluation of pharmaceutical companies: Valuing major quoted pharmaceutical companies; Valuing biotechnology companies and new venture financing; The assessment of research and development; The assessment of product sales potential. Part 3 Pharmaceutical equity trading: Key issues influencing pharmaceutical share price movement; Investment and trading strategy; Dealing in major equity markets.

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
 Shopping cart
Mailing List

 

Sign up now